Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FPHAX vs. FSPHX: which is better?

Bottom line

FPHAX vs FSPHX: the short answer

FPHAX (Pharmaceuticals Portfolio) and FSPHX (Health Care Portfolio) are quite different portfolios: only about 33% of their top holdings (by weight) are shared.

But FSPHX is far broader, holding 152 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.

FSPHX is cheaper at 0.62% vs 0.67% — a difference of $5.00 a year per $10,000 invested.

Over five years, FPHAX returned +12.6% a year vs +4.0% for FSPHX.

Updated Nov 19, 2026

FPHAX vs FSPHX side by side

FPHAXFSPHX
TypeMutual fundMutual fund
Fund familyFidelityFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.67%0.62%
Annual cost per $10k$67$62
10-yr cost on $10k (prospectus)$835$774
Max front load——
12b-1 fee0%0%
1-yr return+30.3%+14.4%
5-yr return (annualized)+12.6%+4.0%
10-yr return (annualized)+10.0%+9.0%
Best quarter+18.5%+22.2%
Worst quarter−13.6%−15.0%
Net assets (fund)$1.5B$5.8B
Number of holdings57152
Portfolio turnover77%69%
Returns as ofApr 30, 2026Apr 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFPHAXFSPHXDifference
2025+30.3%+14.4%+15.9%
2024+9.4%+4.9%+4.5%
2023+12.5%+4.1%+8.4%
2022+1.0%−12.8%+13.8%
2021+11.8%+11.5%+0.3%
2020+11.1%+24.4%−13.4%
2019+31.6%+31.5%+0.2%
2018+5.8%+7.4%−1.6%
2017+10.7%+24.0%−13.3%
2016−16.3%−10.7%−5.6%

Source: Fund prospectus bar charts

Holdings overlap

8 of FPHAX's top 25 holdings also appear in FSPHX's top 25.

Shared top holdings
HoldingFPHAXFSPHX
ELI LILLY and CO28.78%8.03%
Viatris Inc5.45%1.20%
Ucb Sa5.09%2.03%
MERCK and CO INC4.74%1.60%
Gilead Sciences Inc3.97%2.21%
JOHNSON and JOHNSON3.77%4.91%
Fidelity Revere Street Trust2.44%2.17%
Moderna Inc1.57%1.18%

Source: SEC Form N-PORT

FPHAX top 10

  1. ELI LILLY and CO — 28.78%
  2. Gsk Plc — 8.17%
  3. Viatris Inc — 5.45%
  4. Ucb Sa — 5.09%
  5. MERCK and CO INC — 4.74%
  6. Roche Holding Ag — 4.54%
  7. Legend Biotech Corp — 4.53%
  8. Astrazeneca Plc — 4.22%
  9. Elanco Animal Health Inc — 4.15%
  10. Jazz Pharmaceuticals Plc — 4.09%

FSPHX top 10

  1. ELI LILLY and CO — 8.03%
  2. Danaher Corp — 6.89%
  3. JOHNSON and JOHNSON — 4.91%
  4. Thermo Fisher Scientific Inc — 4.33%
  5. Unitedhealth Group Inc — 3.49%
  6. Alnylam Pharmaceuticals Inc — 2.40%
  7. Gilead Sciences Inc — 2.21%
  8. Boston Scientific Corp — 2.17%
  9. Ascendis Pharma A/s — 2.17%
  10. Fidelity Revere Street Trust — 2.17%

FAQ

What is the difference between FPHAX and FSPHX?
FPHAX (Pharmaceuticals Portfolio) and FSPHX (Health Care Portfolio) are quite different portfolios: only about 33% of their top holdings (by weight) are shared. But FSPHX is far broader, holding 152 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.
Which is cheaper, FPHAX or FSPHX?
FSPHX has the lower expense ratio (0.62%).
Should I own both FPHAX and FSPHX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.